Jayasuriya Anula insider trades
Jayasuriya Anula has filed 11 Form 4s with the SEC that we hold, for Lineage Cell Therapeutics, Inc. (LCTX) (Director) and Jaguar Health, Inc. (JAGX) (Director). Across all of them we count 1 purchase worth $10.9K and 0 sales worth $0 reported on Form 4. None of these purchases or sales is dated in the last 12 months. The largest single trade was a purchase of 10,000 shares of Lineage Cell Therapeutics, Inc. worth $10.9K, dated 2023-12-29. The first filing on our record is dated 2021-07-01 and the latest 2026-07-02.
Lineage Cell Therapeutics, Inc. (LCTX)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2023-12-29 | P, purchase reported on Form 4 | 10,000 | $10.9K | 2024-01-02 |
Jaguar Health, Inc. (JAGX)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1822933) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms